These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22437326)

  • 1. Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.
    Ntoufa S; Vardi A; Papakonstantinou N; Anagnostopoulos A; Aleporou-Marinou V; Belessi C; Ghia P; Caligaris-Cappio F; Muzio M; Stamatopoulos K
    Mol Med; 2012 Dec; 18(1):1281-91. PubMed ID: 22437326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
    Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
    J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia.
    Bühler A; Zenz T; Stilgenbauer S
    Clin Cancer Res; 2010 Jan; 16(2):373-5. PubMed ID: 20068107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.
    Kanduri M; Marincevic M; Halldórsdóttir AM; Mansouri L; Junevik K; Ntoufa S; Kultima HG; Isaksson A; Juliusson G; Andersson PO; Ehrencrona H; Stamatopoulos K; Rosenquist R
    Epigenetics; 2012 Dec; 7(12):1435-42. PubMed ID: 23154584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Papadopoulos G; Hatzigeorgiou A; Anagnostopoulos A; Chlichlia K; Ghia P; Muzio M; Belessi C; Stamatopoulos K
    Mol Med; 2013 May; 19(1):115-23. PubMed ID: 23615967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
    Kawauchi K; Ogasawara T; Yasuyama M
    Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
    Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
    Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
    Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
    J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell receptor and antigens in CLL.
    Agathangelidis A; Ntoufa S; Stamatopoulos K
    Adv Exp Med Biol; 2013; 792():1-24. PubMed ID: 24014290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
    Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
    Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
    Front Immunol; 2018; 9():1996. PubMed ID: 30271400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
    Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
    Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.